| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721326 | Clinical Immunology | 2018 | 7 Pages |
Abstract
Increased prevalence of ATA IL10 promoter haplotypes and subsequently reduced IL-10 expression may be an immunological cofactor in individuals genetically predisposed for the development of CD. Resulting cytokine imbalances may be utilized as disease biomarkers in CD.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Hofmann S.R., Laass M.W., Fehrs A., Schuppan D., Zevallos V.F., Salminger D., Mäbert K., Hedrich C.M.,